Peer-influenced content. Sources you trust. No registration required. This is HCN.
Healthgrades for Professionals
Urine color, transparency, and frequency patterns serve as accessible health indicators that patients can monitor independently while recognizing when professional medical evaluation becomes essential.
Emergency Medicine June 17th 2025
Health
Topical finasteride absorption through skin into bloodstream produces adverse events consistent with approved oral finasteride products, with 32 documented cases including erectile dysfunction, anxiety, and cognitive symptoms reported between 2019-2024.
Dermatology May 28th 2025
Oncology News Central (ONC)
Company leadership demands FDA explanation for approving identical treatment in patients with CIS while refusing filing for those without CIS, despite same trial data showing comparable clinical benefits and safety profiles.
Oncology, Medical May 27th 2025
UCLA Health
The procedure addresses limitations of current intestinal reconstruction methods, potentially eliminating associated bleeding risks, infections, and digestive complications while providing more physiologically normal urinary function.
Nephrology May 27th 2025
Endocrinology Advisor
Gepotidacin demonstrated superiority to nitrofurantoin in the EAGLE-3 trial with a therapeutic success rate of 58.9% versus 44%, while maintaining a manageable side effect profile primarily consisting of gastrointestinal disturbances.
Family Medicine/General Practice May 7th 2025
Oncology Learning Network
The results of PROfound and PROpel underscore the importance of identifying the genomic characteristics of the patient and the cancer to guide the selection of the most appropriate treatment for a specific patient type.
Oncology, Medical April 29th 2025